跳至主要内容
临床试验/ACTRN12618001068257
ACTRN12618001068257撤回4 期

A double-blind, randomised controlled trial on the efficacy of Blackmore’s Conceive Well Men in men with oligozoospermia and asthenozoospermia

Michael Chapman0 个研究点目标入组 100 人开始时间: 2018年6月26日最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • 1. Gender: Men
  • 2. Men with female partners who are interested in conceiving
  • 3. A semen analysis in the previous 3 months that result in a sperm count of less than 15 million/ml or sperm motility of less than 30%

排除标准

  • 1. On antioxidant supplements, iron, folic acid or omega three supplements or any nutritional male fertility supplements that affect semen quality in the previous 3 months
  • 2. Had surgical male fertility treatment in medical history

研究者

发起方
Michael Chapman

相似试验

Blackmore’s Conceive Well Men vs placebo in men with... | 临床试验